Presentation is loading. Please wait.

Presentation is loading. Please wait.

STUDY TITLE Presenter Name Presenter Title Duty Location

Similar presentations


Presentation on theme: "STUDY TITLE Presenter Name Presenter Title Duty Location"— Presentation transcript:

1 STUDY TITLE Presenter Name Presenter Title Duty Location
Date of Presentation

2 Briefing Purpose Confirm the Tentatively Selected Plan.
Discuss significant public, technical, and policy comments and their resolution. Discuss significant risks being carried forward in the study Confirms a willing non-Federal sponsor Request Panel endorsement of the TSP. Request feedback and guidance on path forward Request approval to proceed to feasibility level design. This will be a standard slide in the presention

3 Study Authorities List date and blurb of study authority that defines mission area and scope. This should be very brief

4 Authorized Study Area Insert Map This should be very brief

5 Problems/Objectives/Constraints
Focus on problems that are unique to the study and show that the study has Federal Interest Clear, measurable objectives Constraints unique to this study/study area This should be very brief and use a map/visual to tell this story. Could use map from Slide 4.

6 Final Array of Alternatives
Distinctly different alternatives Risks inherent in each alternative Potential impacts Major qualitative and quantitative metrics used for trade off analysis This should be very brief and use a map/visual to tell this story. Could use map from Slide 4.

7 Tentatively Selected Plan
Key features of the TSP Trade-offs between benefits, environmental impacts, costs, policy, legal issues, and sponsor capability that led to selection This should be very brief and use a map/visual to tell this story.

8 Significant Comments ATR/IEPR/Policy/ Public
Only discuss SIGNIFICANT comments that have changed the TSP since the TSP milestone or have high risk when moving forward in the study The bulk of the district presentation should focus on the risks and uncertainties associated with the significant comments, and how the district altered the TSP based on these

9 MSC Quality Assurance MSC confirms that they have done their QA role throughout the study process ATR and IEPR leads can add input here if they deem it necessary

10 Sponsor Views Sponsor may send District a statement to enter here, and this is the time for them to speak of few words of their support of the TSP (whether that is NED or LPP)

11 HQ Policy Review Recap of significant Policy and Legal Review comments and recommendations The OWPR review manager will send these slide to the RIT

12 Risk Register Highlights Confirming the TSP
This reflects the Risk Register summary submitted as a read ahead with issues that have not been covered by other slides Significant Risk Register items added because of review comments that have changed the TSP or are high risks Major part of presentation

13 Risk Register Highlights Path Forward for TSP Refinement
Risks being carried forward into feasibility level design How will the PDT move from TSP to final report / recommendation? This slide is the MOST important part of the presentation. What risks are you carrying forward and what are you doing about them? This should draw on the Risk Register summary read ahead. Modeling, Cost certification, mitigation plan, etc… What does the Sponsor need to do to complete?

14 Feasibility Level Design Remaining Funds Available
Show what can be done within the study constraints (3x3x3) and risks associated with that. Can this study be finished with current funding?

15 Why were these the milestones on this slide?
Project Schedule Why were these the milestones on this slide? TSP Milestone ATR/IEPR/Public/Policy Review Agency Decision Milestone Final Report Milestone CWRB State and Agency Review Chief’s Report Milestone Date (or Projected Date) Feasibility Cost Share Agreement Signed Alternatives Milestone Tentatively Selected Plan Milestone Agency Decision Milestone Civil Works Review Board Chief’s Report What are the risks associated with this current schedule? Can this study be finished with current funding? What are the major risks associated with schedule and funding to completion?

16 Applied Lessons Learned
Lessons learned from previous studies Lessons learned during this study

17 Discussion and Decision


Download ppt "STUDY TITLE Presenter Name Presenter Title Duty Location"

Similar presentations


Ads by Google